Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Cell & Gene Therapy

Stem cell research and commercialization in China...

Bioheng Publishes Positive Results for Universal CAR-T in Hematological Malignancies

Biocytogen and FineImmune Partner on Cell Therapies Targeting Intracellular Antigens

CellOrigin and Qilu to Develop Off-the-Shelf CAR-Macrophage Immunotherapies

Neukio Bio Completes $50 Million Round for Allogenic CAR-T Therapies

Hangzhou Innoforce and Hibiscus Join to Advance Mayo Clinic’s Cell and Gene Therapies

ChinaBio Event
Beijing and Digital
November 8-11, 2022
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
July 27-31, 2022